News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
25-Jun-2007 - Pharmexa-Epimmune, the U.S.-based subsidiary of Pharmexa A/S, presented selected data from its influenza vaccine program at the Influenza Conference entitled, "Options for the Control of Influenza VI," held in Toronto, Ontario, Canada. The company's "universal" vaccine strategy combines the use ...
25-Jun-2007 - Ceregene, Inc. and Genzyme Corporation announced that they have entered into a partnership for the development and commercialization of CERE-120, Ceregene's proprietary lead program for the treatment of Parkinson's disease. Under the terms of the agreement, Genzyme will pay Ceregene a $25 ...
21-Jun-2007 - Enobia Pharma, announced that it has appointed Hal Landy, MD as the Company's VP Medical Affairs & Chief Medical Officer. Dr. Landy, has 15 years of senior management experience in the biopharmaceutical industry. From 2003 through 2007, Dr. Landy served as Vice-President Clinical Development ...
19-Jun-2007 - Basilea Pharmaceutica Ltd. announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMEA) for ceftobiprole by its license partner Janssen-Cilag International NV, a Johnson & Johnson company. This submission is for the use of ceftobiprole in the treatment ...
18-Jun-2007 - GlaxoSmithKline (GSK) and Genmab A/S announced positive primary efficacy data (evaluated at 24 Weeks) to be presented at EULAR 2007, the Annual European Congress of Rheumatology from a Phase II study of ofatumumab (HuMax-CD20(R)) in patients with rheumatoid arthritis (RA). Ofatumumab is being ...
$50 million investment to support new role
15-Jun-2007 - GlaxoSmithKline (GSK) has designated its facility in Laval, Quebec, as the North American headquarters of its innovative vaccines division. The site will conduct leading vaccine research & development (R&D), and is also the administrative centre for the company's vaccines operations in North ...
14-Jun-2007 - Albany Molecular Research, Inc. announced that a compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development, triggering a $1.5 million payment to AMRI. This marks the first milestone in the ongoing research ...
13-Jun-2007 - TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced it has received its second milestone payment from Teva Pharmaceutical Industries for the ...
13-Jun-2007 - Achillion Pharmaceuticals, Inc. announced that Milind Deshpande, Ph.D. has been promoted to Executive Vice President of Research. Dr. Deshpande previously served as the Company's Senior Vice President, and retains his position as Chief Scientific Officer. Dr. Deshpande joined Achillion as Vice ...
13-Jun-2007 - ProMetic BioTherapeutics, Inc., a subsidiary of ProMetic Life Sciences Inc. , and Blue Blood Biotech Corporation have formed a strategic alliance to develop drugs derived from human plasma utilizing ProMetic's proprietary manufacturing process. The alliance between the two companies will ...
© 1997-2024 LUMITOS AG, All rights reserved